Evidence map›Paper›PMID 21436070›Full record

ArticleBlood2011

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

Delphine Sauce, Martin Larsen, Solène Fastenackels, Michèle Pauchard, Hocine Ait-Mohand, Luminita Schneider, Amélie Guihot, Faroudy Boufassa, John Zaunders, Malika Iguertsira and 14 more

Abstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 158 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Prolonged experimental CD4Nature communications · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. HIV-1Biology direct · 2021
    Article
  17. Article
  18. Review
  19. Review
  20. CD8Frontiers in microbiology · 2021
    Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 3 countries.

Delphine SauceInserm UMR S 945, Infections and Immunity, Avenir Group, Universitě Pierre et Marie Curie-Paris 6, Hôpital Pitiě-Salpêtrière, Paris, France.
Martin Larsen
Solène Fastenackels
Michèle Pauchard
Hocine Ait-Mohand
Luminita Schneider
Amélie Guihot
Faroudy Boufassa
John Zaunders
Malika Iguertsira
Michelle Bailey
Guy Gorochov
Claudine Duvivier
Guislaine Carcelain
Anthony D Kelleher
Anne Simon
Laurence Meyer
Dominique Costagliola
Steven G Deeks
Olivier Lambotte
Brigitte Autran
Peter W Hunt
Christine Katlama
Victor Appay
Assistance Publique – Hôpitaux de Paris · FRInserm · FRSorbonne Université · FRUNSW Sydney · AUUniversity of California, San Francisco · USBicêtre Hospital · FRInstitut Pasteur · FRUniversité Paris-Sud · FR

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
The impact of early antiretroviral therapy on HIV persistence and inflammationR01AI087145 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2009 to 2010
$1.6M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
The Determinants of T Cell Activation in HIV InfectionK23AI065244 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2005 to 2009
$716k
NCRR NIH HHS UL1 RR024131NIAID NIH HHS K23 AI065244NIAID NIH HHS K24 AI069994NIAID NIH HHS K24AI069994NIAID NIH HHS P0AI27763NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI087145
6 · The paper itself

Abstract

The mechanisms of CD4(+) T-cell count decline, the hallmark of HIV disease progression, and its relationship to elevated levels of immune activation are not fully understood. Massive depletion of CD4(+) T cells occurs during the course of HIV-1 infection, so that maintenance of adequate CD4(+) T-cell levels probably depends primarily on the capacity to renew depleted lymphocytes, that is, the lymphopoiesis. We performed here a comprehensive study of quantitative and qualitative attributes of CD34(+) hematopoietic progenitor cells directly from the blood of a large set of HIV-infected persons compared with uninfected donors, in particular the elderly. Our analyses underline a marked impairment of primary immune resources with the failure to maintain adequate lymphocyte counts. Systemic immune activation emerges as a major correlate of altered lymphopoiesis, which can be partially reversed with prolonged antiretroviral therapy. Importantly, HIV disease progression despite elite control of HIV replication or virologic success on antiretroviral treatment is associated with persistent damage to the lymphopoietic system or exhaustion of lymphopoiesis. These findings highlight the importance of primary hematopoietic resources in HIV pathogenesis and the response to antiretroviral treatments.

Indexed as

CD4 Lymphocyte CountAdultCell SeparationDisease ProgressionFlow CytometryHematopoietic Stem CellsHIV-1HIV InfectionsHumansLymphopoiesisMiddle AgedVirus Replication

Identifiers

PMID21436070
PMCPMC3109539
OpenAlexW2048923715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.